William Angus is an accomplished professional in the field of pharmaceutical development and risk assessment, currently serving as Director and Principal Scientist in Toxicology at Biogen since April 2018. With nineteen years of experience at Pfizer as an Associate Research Fellow prior to joining Biogen, William Angus has led nonclinical strategies and safety team representation for over 25 preclinical programs and multiple clinical phases, including significant contributions to the early development and regulatory processes for Ibrance. Expertise spans various therapeutic areas, including the central nervous system, oncology, and rare diseases, and encompasses a diverse range of program types such as small molecules and gene therapy. William Angus holds a PhD in Pharmacology/Toxicology from Michigan State University and a Bachelor of Science in Biology from Hope College.
This person is not in any teams
This person is not in any offices